Locations:
Search IconSearch

Risk of Deep Vein Thrombosis in Patients with IBD: Choosing a Catheter for Parenteral Nutrition

Rate is lower with tunneled intravenous catheters

20-DDI-1971367-CQD-Tunneled-Intravenous-Catheters

Patients with inflammatory bowel disease (IBD) who received home parenteral nutrition (HPN) via tunneled catheters had a lower risk of deep vein thrombosis (DVT) than patients whose HPN was delivered via peripherally inserted catheters (PICCs), according to a study presented at the American College of Gastroenterology 2020 Annual Meeting.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Patients with IBD are at a higher risk of DVT than the general population,” says Mohamed Tausif Siddiqui, MD, fellow in the Department of Gastroenterology, Hepatology and Nutrition in Cleveland Clinic’s Digestive Disease & Surgery Institute, and presenter of the study. “Add in catheters for parenteral nutrition, and the risk increases even more. We wanted to investigate whether a particular type of catheter was safer for these patients.”

Comparing PICCs and tunneled catheters

The team conducted a retrospective analysis of patients with ulcerative colitis and Crohn’s disease who received HPN from 2013 to 2019. A total of 407 patients and 744 catheter placements with a total duration of 317,777 days were analyzed. PICCs were placed in 205 (28%) of episodes, and the rest had tunneled catheters, which were also used for significantly longer periods compared with PICCs.

The overall rate of catheter-associated DVT was 4.4%. The study noted that the rate of catheter-associated DVT was 5.4% in patients with PICC lines compared with 4.1 % in those with tunneled catheters. When reviewing the rates by catheter days, PICCs had twice the rate of DVT compared with tunneled catheters (0.16 vs. 0.08 per 1000 catheter days, respectively). Since the tunneled catheters were used for significantly longer periods, the research team conducted a weighted analysis of the data. They used catheter days as weight for each episode and calculated an odds ratio (OR), which demonstrated that DVT risk was significantly higher with the use of PICCs (OR 3.665, 95% CI 3.516-3.820, P < 0.05).

Advertisement

“The data confirms our choice at Cleveland Clinic to use tunneled central lines for the majority of our IBD patients on home parenteral nutrition, especially when the duration of therapy is greater than four to six weeks,” says Donald Kirby, MD, Director of Cleveland Clinic’s Center for Human Nutrition. “PICCs are placed into smaller lumen veins compared with tunneled catheters, and thereby should be at higher risk of thrombosis. It has been our team’s long-term goal to minimize the potential complications that these patients experience.“

Center for Human Nutrition

Cleveland Clinic’s Center for Human Nutrition enables the comprehensive evaluation, education and treatment of patients with disease-related nutrition problems. This innovative approach allows registered dietitians, dietetic technicians, nurses, pharmacists, physicians and surgeons to provide individualized plans for both adults and pediatric patients with specialized nutrition needs. The center focuses on three distinct areas: nutrition therapy, nutrition support and intestinal rehabilitation.

Extensive collaboration between the center and the IBD medical home led by Department Chair Miguel Regueiro, MD, was key to this research. “This research demonstrates our focus on whole-person care,” he says. “Patients in our IBD medical home get a one-stop shop for all kinds of expertise, including the Center for Human Nutrition, all led by their gastroenterologist.” Read more about the IBD medical home here.

Advertisement

Related Articles

Illustration of J pouch
May 21, 2026/Digestive/Research

Ulcerative Colitis Patients with Pyoderma Gangrenosum Have Worse Outcomes with J-Pouch Surgery, Study Finds

Patients have a significantly higher risk of developing fistulas and experiencing future Crohn’s-like changes

Dr. Gorgun in operating room
May 20, 2026/Digestive/Research

Cleveland Clinic Colorectal Surgeons Develop a New Standardized Endoscopic Grading System for Rectal Cancer Response and Organ Preservation

Cleveland Clinic researchers developed an objective tool to assess response following total neoadjuvant therapy.

Patient speaking with physicians
May 11, 2026/Digestive/Research

Adherence to Lifestyle Changes Peaks One Month After Bariatric Surgery, Study Finds

Patients may benefit from booster appointments, psychological support

Dr. Aminian in OR
May 7, 2026/Digestive/Research

Metabolic Surgery May Reverse MASH Cirrhosis, Paired Biopsy Study Suggests

Research demonstrates cirrhosis regression in one-third of patients, with higher rates using alternative assessment

Dr. Regueiro speaking with patient
May 6, 2026/Digestive/Research

Patients With IBD Who Undergo Colon Cancer Surgery Have Higher Blood Clot Risk

Elevated risk persists for more than a year after surgery, plus more insights from the first study to quantify risk specifically for CRC surgery

Pharmacist filling order
May 5, 2026/Digestive/Research

Fenofibrate-UDCA Combination Therapy Safe and Effective for Primary Biliary Cholangitis

Large, retrospective study indicates improved outcomes after one and five years of treatment

Dr. Bhatt with clinician
April 28, 2026/Digestive/Innovation

Endorobotics Collaborative: A New Era in Gastrointestinal Procedures

Multidisciplinary collaboration is fueling breakthroughs in endoscopic and surgical technology

Dr. Kwan and Dr. Hashimoto performing Laparoscopic Liver Transplant Surgery
April 9, 2026/Digestive/Transplant

Transforming Liver Transplantation at Cleveland Clinic

A surge in transplants, advanced surgical techniques and multidisciplinary collaboration has helped shape and expand the Liver Transplant Program

Ad